Chair

Hironobu Saito

Vice President, Oncology Clinical Development Department, Oncology Function, R&D Division, for Daiichi Sankyo Co., Ltd., Japan

  
Hironobu Saito, PhD, serves as Vice President, Oncology Clinical Development Department, Oncology Function, R&D Division, for Daiichi Sankyo Co., Ltd., Japan. He joined Daiichi Sankyo as a member of the research division, subsequently became a leader in the clinical strategic team, and thereafter assumed responsibility for development in Asia. Dr. Saito has served as the JPMA representative to the ICH Steering Committee, and was Chair of the ICH Project Committee in the JPMA from 2012-2016. Dr. Saito has received the DIA Japan Outstanding Service Award, and earned his PhD from Chiba University.
Members
  • Hiroyuki Aono

    Senior Advisor, Research and Development Solutions Center of Excellence, IQVIA Services Japan K.K.

  • Toru Fujieda

    President, CMIC Co., Ltd.

  • Shinzo Hiroi

    Head of Global Medical Affairs, Shionogi & Co., Ltd.

  • Katsuhiko Ichimaru

    Director for MID-NET project, Pharmaceuticals and Medical Devices Agency (PMDA)

  • Junichi Imagawa

    Department Manager, Drug Safety Coordination Department, Drug Safety Division, Chugai Pharmaceutical Co., Ltd.

  • Yoichi Ishikawa

    Professor, Department of Pediatric Medication, Meiji Pharmaceutical University

  • Noriatsu Kono

    Managing Director, Department of Innovative Drug Discovery and Development, Japan Agency for Medical Research and Development (AMED)

  • Hideki Maeda

    Professor, Department of Regulatory Science, Faculty of Pharmaceutical Sciences, Meiji Pharmaceutical University

  • Rie Matsui

    Senior Director, Regional Labeling Head for APAC, Pfizer R&D Japan

  • Noriko Morishita

    Manager, Clinical Trial Promotion Office, National Hospital Organization Headquarter

  • Harumasa Nakamura

    Director of Clinical Research Support Office, Translational Medical Center, National Center of Neurology and Psychiatry

  • Junichi Nishino

    Director, Medical Regulatory Affairs Department , Otsuka Pharmaceutical Co., Ltd.

  • Satoshi Saeki

    Senior Director, Japan-Asia Clinical Development 2, Astellas Pharma Inc.

  • Takuko Sawada

    Director of the Board, Executive Vice President, Shionogi & Co., Ltd.

  • Shuji Sumida

    Senior Specialist, Business Strategy & Compliance Department, Chugai Pharmaceutical Co., Ltd.

  • Akiko Takahashi

    Division Director, Division of Planning and Coordination, Pharmaceuticals and Medical Devices Agency (PMDA)

  • Hisashi Urushihara

    Professor, Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University

  • Noboru Yamamoto

    Deputy Director, Department of Experimental Therapeutics, National Cancer Center Hospital